Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 140 participants.

Also called NCT01239004

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 140 participants (enrolled count) (from the registry)
Sponsor
Radiant Research (from the registry)
Registry
  • NCT NCT01239004
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01239004. Randomized; quadruple masking; primary purpose prevention. Start 2010-11 (registry gives no type); primary completion 2011-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy
Acronym
CERTAIN
Condition
Dyslipidemia
Condition
Hyperlipidemia
Condition
Hyperglycemia
Intervention (Drug)
Placebo
Intervention (Drug)
Colesevelam
Lead sponsor
Radiant Research (class: other)

Record details

Record id
cardio:ct-nct01239004
Content hash
4ca54d639b643673268980a96af1fe2ee4f5889fb94d093ddd34f97fda6a1363